Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways. - Wikidata - awgldk - TriplyDB

Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways.

Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways.

http://www.wikidata.org/entity/Q37100734

about

Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors.The Adhesion G-Protein-Coupled Receptor, GPR56/ADGRG1, Inhibits Cell-Extracellular Matrix Signaling to Prevent Metastatic Melanoma Growth.

P2860

Q48363650-91840D1E-32C3-4FCA-9872-D819C0F81B92 Q49449261-0798B475-E0C1-40AD-AB8E-198CA9663F3C

P2860

Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways.

http://www.wikidata.org/entity/Q37100734

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Efficacy of focal adhesion kin ...... cally activated MAPK pathways.

@en

Efficacy of focal adhesion kin ...... cally activated MAPK pathways.

@nl

type

label

Efficacy of focal adhesion kin ...... cally activated MAPK pathways.

@en

Efficacy of focal adhesion kin ...... cally activated MAPK pathways.

@nl

prefLabel

Efficacy of focal adhesion kin ...... cally activated MAPK pathways.

@en

Efficacy of focal adhesion kin ...... cally activated MAPK pathways.

@nl

P1433

Q37100734-5E2668A6-511A-486F-9FCF-AEDC14FF990E

P1476

Q37100734-2CB73B56-A2CA-4465-9108-5EF9029796A1

P2093

Q37100734-0EF32535-0181-44FA-B265-8017DB55C6DD

Q37100734-4CCFBAA4-4791-4B0F-BB68-40F7A5E21343

Q37100734-5C9C14D8-7973-4808-BEBE-6A502FD4604D

Q37100734-724DFDEF-800A-4A4C-ABD3-C520B3B349D1

Q37100734-7AC3C34D-E02B-48BE-A292-62BCAAA039CD

Q37100734-7E620557-DB0D-4606-A274-0335F7B0F7DA

Q37100734-8FDA3D76-C7D3-4866-9C2A-AE9A695F4E67

P2860

Q37100734-0D8F7241-5ABB-44BE-B43D-56A4790D2C82

Q37100734-0FEF95A5-E3B1-4723-8DF6-BAADC3EAB690

Q37100734-110E0A58-280E-4EAA-BDA4-1D65B240A0EB

Q37100734-152BDC4D-AA30-43F1-A2F7-21430424DADA

Q37100734-22F95F33-317C-4F51-872E-A59C9463D748

Q37100734-26549AFF-2C46-41D0-83ED-2344CA0DB31F

Q37100734-26E8A3ED-6760-4F9E-AF9F-DB1C1790046E

Q37100734-28A7B249-4767-43D1-BA98-F0890FDF7568

Q37100734-2A9AAD6E-95F5-4918-8DCD-1CD71C0CEBF6

Q37100734-3471DA77-8437-4D3B-A474-F760AD3B028D

P2888

Q37100734-15D4EB76-9DC9-4B30-8B2B-B90170F3BF82

P304

Q37100734-96067F6B-EB70-45F1-BAFF-E7D301574483

P31

Q37100734-E0E6FCD1-B8E9-4585-B1EA-258BE4C832AE

P356

Q37100734-2E95D989-DAD3-466F-BF4B-93826C157C97

P407

Q37100734-DDF98AB0-E130-47E6-9B80-0E386AB685AC

P433

Q37100734-C8C0BE7F-7D36-43BA-AE2F-BD40566815B6

P478

Q37100734-9811548F-2EA4-48D8-884A-148369F4C495

P577

Q37100734-A14663FA-13C9-4E35-BB85-A1FF87B4B513

P6179

Q37100734-6C69C162-BEF4-4904-AB9C-12D2BC206C8F

P698

Q37100734-882E84B3-920A-460C-91DA-383EE0B212DA

P932

Q37100734-D9DDAFEB-2714-4A19-8209-F7184AB793B0

P356

P1433

British Journal of Cancer

P1476

Efficacy of focal adhesion kin ...... cally activated MAPK pathways.

@en

P2093

Alex A Adjei

http://www.w3.org/2001/XMLSchema#string

Grace K Dy

http://www.w3.org/2001/XMLSchema#string

Hao Zhang

http://www.w3.org/2001/XMLSchema#string

Hongbin Chen

http://www.w3.org/2001/XMLSchema#string

Huanjie Shao

http://www.w3.org/2001/XMLSchema#string

Vita M Golubovskaya

http://www.w3.org/2001/XMLSchema#string

William Cance

http://www.w3.org/2001/XMLSchema#string

P2860

Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors

A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response.

A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer.

Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase

BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations

Evolving Therapies and FAK Inhibitors for the Treatment of Cancer

BCL-2 family members and the mitochondria in apoptosis

Focal adhesion kinase: in command and control of cell motility

The Bcl-2 protein family: arbiters of cell survival

Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma

P2888

P304

203-211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2016.190

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1001170719

http://www.w3.org/2001/XMLSchema#string

P698

27336608

http://www.w3.org/2001/XMLSchema#string

P932

4947704

http://www.w3.org/2001/XMLSchema#string